All In Biotech

Drug Trial Radar · NCT05072314

Long-term Outcomes of Lidocaine Infusions for Post-Operative Pain (LOLIPOP) Trial

Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 4,300 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

4,300

Planned (sponsor's estimate)

Start

Jul 27, 2022

Primary completion

May 2028

Study completion May 2029

Sponsor

Lead sponsor
Monash UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Royal Perth Hospital
First posted
Oct 8, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The LOLIPOP Trial is a large (n=4,300 patients) pragmatic, international, multicentre, prospective, randomised, double blind, placebo-controlled, parallel assessment, safety and effectiveness superiority study.

Conditions

  • Breast Cancer
  • Breast Cancer Female
  • Breast Conserving Surgery
  • Mastectomy

Interventions

  • lidocaine 2% and 10%Drug

    Lidocaine infusion: 1. Commencing with an intravenous bolus after induction of anaesthesia, 0.125 ml/kg of lean body weight (LBW) of 2% lidocaine (2.5 mg/kg).\* 2. Followed by a 2% lidocaine intravenous infusion for the duration of surgery, 0.1665 ml/kg/h of LBW (3.33 mg/kg/hr).\* 3. A post-operative subcutaneous 0.0222 ml/kg/hr of LBW 10% lidocaine infusion for up to 24 hours thereafter (2.22 mg/kg/hr). Dosage will be capped at a maximum lean body weight of 68kg. * \*Day-case surgery receives intraoperative bolus and intraoperative infusion only

  • PlaceboDrug

    Placebo infusion: 1. Commencing with an intravenous bolus after induction of anaesthesia, 0.125 ml/kg of lean body weight (LBW) of 0.9% Saline solution.\* 2. Followed by a 0.9% Saline solution intravenous infusion for the duration of surgery, 0.1665 ml/kg/h of LBW (3.33 mg/kg/hr).\* 3. A post-operative subcutaneous 0.0222 ml/kg/hr of LBW 0.9% Saline solution infusion for up to 24 hours thereafter (2.22 mg/kg/hr). Dosage will be capped at a maximum lean body weight of 68kg. * \*Day-case surgery receives intraoperative bolus and intraoperative infusion only

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The incidence of moderate or severe CPSP at 1 year after surgery, as reported by the patient at the follow-up review.Time frame: 1 year post-surgery

Locations

49 sites in 4 countries. Site status is shown where the registry gives one.

  • Nepean Hospital

    Kingswood, New South Wales, Australia · Recruiting

  • Blacktown Mount Druitt Hospital

    Mount Druitt, New South Wales, Australia · Recruiting

  • Royal North Shore Hospital

    Sydney, New South Wales, Australia · Recruiting

  • Westmead Hospital

    Sydney, New South Wales, Australia · Completed

  • St George Hospital

    Sydney, New South Wales, Australia · Recruiting

  • Royal Brisbane and Women's Hospital

    Brisbane, Queensland, Australia · Completed

  • Queen Elizabeth II Jubilee Hospital

    Coopers Plains, Queensland, Australia · Active not recruiting

  • Mackay Base Hospital

    Mackay, Queensland, Australia · Active not recruiting

  • Rockhampton Hospital

    Rockhampton, Queensland, Australia · Completed

  • Gold Coast Hospital and Health Service- Gold Coast University Hospital

    Southport, Queensland, Australia · Completed

  • Princess Alexandra Hospital

    Woolloongabba, Queensland, Australia · Recruiting

  • Flinders Medical Centre

    Bedford Park, South Australia, Australia · Recruiting

  • Royal Hobart Hospital

    Hobart, Tasmania, Australia · Recruiting

  • Anaesthetic Group Ballarat

    Ballarat, Victoria, Australia · Completed

  • Ballarat Health Services (Grampians Health)

    Ballarat, Victoria, Australia · Active not recruiting

  • Barwon Health - University Hospital Geelong

    Geelong, Victoria, Australia · Recruiting

  • The Alfred

    Melbourne, Victoria, Australia · Recruiting

  • Royal Melbourne Hospital

    Melbourne, Victoria, Australia · Active not recruiting

  • St Vincent's Hospital Melbourne

    Melbourne, Victoria, Australia · Recruiting

  • Northern Hospital

    Melbourne, Victoria, Australia · Withdrawn

  • Monash Health - Moorabbin Hospital

    Melbourne, Victoria, Australia · Completed

  • Maroondah Hospital - Eastern Health

    Ringwood East, Victoria, Australia · Recruiting

  • Goulburn Valley Health

    Shepparton, Victoria, Australia · Completed

  • Latrobe Regional Hospital

    Traralgon, Victoria, Australia · Withdrawn

  • Bentley Health Service

    Bentley, Western Australia, Australia · Recruiting

  • Royal Perth Hospital

    Perth, Western Australia, Australia · Recruiting

  • St John of God Subiaco

    Perth, Western Australia, Australia · Recruiting

  • Pamela Youde Nethersole Eastern Hospital

    Chai Wan, Hong Kong · Recruiting

  • Ruttonjee Hospital

    Wan Chai, Hong Kong · Recruiting

  • North District Hospital

    Shatin, Sha Tin, Hong Kong · Recruiting

  • Auckland City Hospital

    Auckland, Auckland, New Zealand · Recruiting

  • Middlemore Hospital

    Auckland, Middlemore, New Zealand · Recruiting

  • Waikato Hospital

    Hamilton, Waikato Region, New Zealand · Recruiting

  • Belfast City Hospital

    Belfast, United Kingdom · Recruiting

  • Southmead Hospital, North Bristol Trust

    Bristol, United Kingdom · Recruiting

  • Darlington Memorial Hospital

    Darlington, United Kingdom · Terminated

  • Russells Hall Hospital

    Dudley, United Kingdom · Recruiting

  • Royal Liverpool and Broadgreen Hospitals

    Liverpool, United Kingdom · Recruiting

  • Whittington Hospital

    London, United Kingdom · Recruiting

  • Royal Marsden Hospital - London and Sutton

    London, United Kingdom · Recruiting

Showing 40 of 49 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.